Angion Biomedica - Stock Price History | ANGN

Historical daily share price chart and data for Angion Biomedica since 2021 adjusted for splits. The latest closing stock price for Angion Biomedica as of September 27, 2021 is 10.40.
  • The all-time high Angion Biomedica stock closing price was 25.74 on February 22, 2021.
  • The Angion Biomedica 52-week high stock price is 26.30, which is 152.9% above the current share price.
  • The Angion Biomedica 52-week low stock price is 9.03, which is 13.2% below the current share price.
  • The average Angion Biomedica stock price for the last 52 weeks is 14.22.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Angion Biomedica Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.310B $0.003B
Angion Biomedica Corp. is a late-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases. Angion Biomedica Corp. is based in UNIONDALE, N.Y.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29